Llwytho...
DD-04 PENAO: A POTENT MITOCHONDRIAL TARGETED INHIBITOR FOR GLIOBLASTOMA
PENAO (4-(N-(S-penicillaminylacetyl)amino)phenylarsonous acid) is a promising new treatment for glioblastoma patients and is currently in Phase-I clinical trial testing. PENAO selectively targets cancer-specific mitochondrial metabolism by binding to the inner-mitochondrial membrane protein adenine...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218034/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou246.4 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|